Here are four things to know.
1. Integra develops products for neurosurgery, reconstruction, wound and dental care.
2. Codman neurosurgery business — part of J&J’s DePuy Synthes unit — offers a portfolio of tissue ablation, spinal cord repair and cranial stabilization products.
3. Integra made a “binding offer” for the Codman business, although the deal is still pending approval from various works councils and regulators, a J&J spokeswoman told Reuters.
4. If approved by various works councils and regulators, the deal will close in the fourth quarter of 2017.
More articles on supply chain:
Skin cream costs vary based on prescribing provider, study finds
Hologic to acquire Cynosure for $1.6B: 3 things to know
Former FDA commissioner shares 4 thoughts on streamlining drug approvals
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
